Professor Mark Blaskovich is an antibiotic hunter and Director of Translation at the Institute for Molecular Bioscience at The University of Queensland. He is co-founder and former Director of the Centre for Superbug Solutions at IMB.
A medicinal chemist with 15 years of industrial drug development experience prior to his academic career, Mark has been developing new antibiotics to treat drug resistant pathogens and using modified antibiotics to detect bacterial infections. He is a co-founder of the Community for Open Antimicrobial Drug Discovery, a global antibiotic discovery initiative, and has led a number of UQ-industry collaborations focused on antibiotic development. An inventor on eleven patent families, Mark has developed drugs in clinical trials, published more than eighty research articles, and received over $10m in grant funding.
Journal Article: How to stimulate and facilitate early stage antibiotic discovery
Zuegg, Johannes, Hansford, Karl A., Elliott, Alysha G., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). How to stimulate and facilitate early stage antibiotic discovery. ACS Infectious Diseases, 6 (6), 1302-1304. doi: 10.1021/acsinfecdis.0c00163
Journal Article: Metal complexes as a promising source for new antibiotics
Frei, Angelo, Zuegg, Johannes, Elliott, Alysha G., Baker, Murray V., Braese, Stefan, Brown, Christopher, Chen, Feng, Dowson, Christopher Gerard, Dujardin, Gilles, Jung, Nicole, King, A. Paden, Mansour, Ahmed Moustafa, Massi, Massimiliano, Moat, John, Mohamed, Heba A., Renfrew, Anna, Rutledge, Peter, Sadler, Peter J., Todd, Matthew Houghton, Willans, Charlotte E., Wilson, Justin Jeff, Cooper, Matthew Allister and Blaskovich, Mark (2020). Metal complexes as a promising source for new antibiotics. Chemical Science, 11 (10), 2627-2639. doi: 10.1039/c9sc06460e
Journal Article: Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux
Stone, M. Rhia L., Masi, Muriel, Phetsang, Wanida, Pagès, Jean-Marie, Cooper, Matthew A. and Blaskovich, Mark A. T. (2019). Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux. MedChemComm, 10 (6), 901-906. doi: 10.1039/c9md00124g
Journal Article: The diminished antimicrobial pipeline
Blaskovich, Mark A.T. (2019). The diminished antimicrobial pipeline. Microbiology Australia, 40 (2), 92-96. doi: 10.1071/MA19025
Journal Article: Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich, Mark A. T., Pitt, Miranda E., Elliott, Alysha G. and Cooper, Matthew A. (2018). Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?. Expert Review of Anti-infective Therapy, 16 (6), 485-499. doi: 10.1080/14787210.2018.1483240
Journal Article: Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance
Stone, M Rhia L., Butler, Mark S., Phetsang, Wanida, Cooper, Matthew A. and Blaskovich, Mark A. T. (2018). Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance. Trends in Biotechnology, 36 (5), 523-536. doi: 10.1016/j.tibtech.2018.01.004
Journal Article: Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria
Velkov, Tony, Gallardo-Godoy, Alejandra, Swarbrick, James D., Blaskovich, Mark A. T., Elliott, Alysha G., Han, Meiling, Thompson, Philip E., Roberts, Kade D., Huang, Johnny X., Becker, Bernd, Butler, Mark S., Lash, Lawrence H., Henriques, Sónia Troeira, Nation, Roger L., Sivanesan, Sivashangarie, Sani, Marc-Antoine, Separovic, Frances, Mertens, Haydyn, Bulach, Dieter, Seemann, Torsten, Owen, Jeremy, Li, Jian and Cooper, Matthew A. (2018). Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria. Cell Chemical Biology, 25 (4), 380-391.e5. doi: 10.1016/j.chembiol.2018.01.005
Journal Article: Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
Blaskovich, Mark A T, Hansford, Karl A., Gong, Yujing, Butler, Mark S., Muldoon, Craig, Huang, Johnny X., Ramu, Soumya, Silva, Alberto B., Cheng, Mu, Kavanagh, Angela M., Ziora, Zyta, Premraj, Rajaratnam, Lindahl, Fredrik, Bradford, Tanya A., Lee, June C., Karoli, Tomislav, Pelingon, Ruby, Edwards, David J., Amado, Maite, Elliott, Alysha G, Phetsang, Wanida, Daud, Noor Huda, Deecke, Johan E, Sidjabat, Hanna E, Ramaologa, Sefetogi, Zuegg, Johannes, Betley, Jason R, Beevers, Andrew P G, Smith, Richard A G ... Cooper, Matthew A. (2018). Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Nature Communications, 9 (1) 02123, 22. doi: 10.1038/s41467-017-02123-w
Journal Article: Unusual amino acids in medicinal chemistry
Blaskovich, Mark A. T. (2016). Unusual amino acids in medicinal chemistry. Journal of Medicinal Chemistry, 59 (24), 10807-10836. doi: 10.1021/acs.jmedchem.6b00319
Journal Article: Antibiotics in the clinical pipeline at the end of 2015
Butler, Mark S., Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Antibiotics in the clinical pipeline at the end of 2015. The Journal of Antibiotics, 70 (1), 1-22. doi: 10.1038/ja.2016.72
Journal Article: Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli
Phetsang, Wanida, Pelingon, Ruby, Butler, Mark S., KC, Sanjaya, Pitt, Miranda, Kaeslin, Geraldine, Cooper, Matthew A. and Blaskovich, Mark A. T. (2016). Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli. ACS Infectious Diseases, 2 (10), 688-701. doi: 10.1021/acsinfecdis.6b00080
Book: Handbook on syntheses of amino acids : General routes for the syntheses of amino acids
Blaskovich, Mark A (2010). Handbook on syntheses of amino acids : General routes for the syntheses of amino acids. First ed. New York , NY, U.S.A.: Oxford University Press; American Chemical Society.
(2023–2028) ARC Industrial Transformation Training Centres
(2023–2024) Griffith University
(2023) CSIRO
Understanding Molecular Accumulation in antimicrobial resistant microbes
Doctor Philosophy
(2023) Doctor Philosophy
(2023) Doctor Philosophy
Functionalised antibiotics for diagnostics and therapeutics
The increasing incidence of infections caused by drug resistant bacteria and fungi poses a significant and increasing threat to global human health, with predicted annual mortality of 10 million people by 2050. It is imperative to advance new technologies capable of rapidly and accurately diagnosing infections to enable timely and appropriate therapy. We must develop new antibiotics with efficacy against multidrug-resistant bacteria and fungi, and new methods to rapidy diagnose infections. To enable this we require fundamental studies that probe the chemical biology of antibiotic action and investigate microbial growth, metabolism and resistance.
This research program is designed to achieve these goals, based on the chemical functionalisation of antibiotics with a readily derivatised handle. The resulting set of versatile intermediates is then modified to create 1) fluorescent probes that can catalyse basic research and lead to new assays, 2) clinical imaging agents to visualise microbial infections, and 3) novel hybrid therapeutics. The project requires talented synthetic organic chemists with an interest in multidisciplinary research.
How to stimulate and facilitate early stage antibiotic discovery
Zuegg, Johannes, Hansford, Karl A., Elliott, Alysha G., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). How to stimulate and facilitate early stage antibiotic discovery. ACS Infectious Diseases, 6 (6), 1302-1304. doi: 10.1021/acsinfecdis.0c00163
Metal complexes as a promising source for new antibiotics
Frei, Angelo, Zuegg, Johannes, Elliott, Alysha G., Baker, Murray V., Braese, Stefan, Brown, Christopher, Chen, Feng, Dowson, Christopher Gerard, Dujardin, Gilles, Jung, Nicole, King, A. Paden, Mansour, Ahmed Moustafa, Massi, Massimiliano, Moat, John, Mohamed, Heba A., Renfrew, Anna, Rutledge, Peter, Sadler, Peter J., Todd, Matthew Houghton, Willans, Charlotte E., Wilson, Justin Jeff, Cooper, Matthew Allister and Blaskovich, Mark (2020). Metal complexes as a promising source for new antibiotics. Chemical Science, 11 (10), 2627-2639. doi: 10.1039/c9sc06460e
Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux
Stone, M. Rhia L., Masi, Muriel, Phetsang, Wanida, Pagès, Jean-Marie, Cooper, Matthew A. and Blaskovich, Mark A. T. (2019). Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux. MedChemComm, 10 (6), 901-906. doi: 10.1039/c9md00124g
The diminished antimicrobial pipeline
Blaskovich, Mark A.T. (2019). The diminished antimicrobial pipeline. Microbiology Australia, 40 (2), 92-96. doi: 10.1071/MA19025
Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich, Mark A. T., Pitt, Miranda E., Elliott, Alysha G. and Cooper, Matthew A. (2018). Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?. Expert Review of Anti-infective Therapy, 16 (6), 485-499. doi: 10.1080/14787210.2018.1483240
Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance
Stone, M Rhia L., Butler, Mark S., Phetsang, Wanida, Cooper, Matthew A. and Blaskovich, Mark A. T. (2018). Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance. Trends in Biotechnology, 36 (5), 523-536. doi: 10.1016/j.tibtech.2018.01.004
Velkov, Tony, Gallardo-Godoy, Alejandra, Swarbrick, James D., Blaskovich, Mark A. T., Elliott, Alysha G., Han, Meiling, Thompson, Philip E., Roberts, Kade D., Huang, Johnny X., Becker, Bernd, Butler, Mark S., Lash, Lawrence H., Henriques, Sónia Troeira, Nation, Roger L., Sivanesan, Sivashangarie, Sani, Marc-Antoine, Separovic, Frances, Mertens, Haydyn, Bulach, Dieter, Seemann, Torsten, Owen, Jeremy, Li, Jian and Cooper, Matthew A. (2018). Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria. Cell Chemical Biology, 25 (4), 380-391.e5. doi: 10.1016/j.chembiol.2018.01.005
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
Blaskovich, Mark A T, Hansford, Karl A., Gong, Yujing, Butler, Mark S., Muldoon, Craig, Huang, Johnny X., Ramu, Soumya, Silva, Alberto B., Cheng, Mu, Kavanagh, Angela M., Ziora, Zyta, Premraj, Rajaratnam, Lindahl, Fredrik, Bradford, Tanya A., Lee, June C., Karoli, Tomislav, Pelingon, Ruby, Edwards, David J., Amado, Maite, Elliott, Alysha G, Phetsang, Wanida, Daud, Noor Huda, Deecke, Johan E, Sidjabat, Hanna E, Ramaologa, Sefetogi, Zuegg, Johannes, Betley, Jason R, Beevers, Andrew P G, Smith, Richard A G ... Cooper, Matthew A. (2018). Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Nature Communications, 9 (1) 02123, 22. doi: 10.1038/s41467-017-02123-w
Unusual amino acids in medicinal chemistry
Blaskovich, Mark A. T. (2016). Unusual amino acids in medicinal chemistry. Journal of Medicinal Chemistry, 59 (24), 10807-10836. doi: 10.1021/acs.jmedchem.6b00319
Antibiotics in the clinical pipeline at the end of 2015
Butler, Mark S., Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Antibiotics in the clinical pipeline at the end of 2015. The Journal of Antibiotics, 70 (1), 1-22. doi: 10.1038/ja.2016.72
Phetsang, Wanida, Pelingon, Ruby, Butler, Mark S., KC, Sanjaya, Pitt, Miranda, Kaeslin, Geraldine, Cooper, Matthew A. and Blaskovich, Mark A. T. (2016). Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli. ACS Infectious Diseases, 2 (10), 688-701. doi: 10.1021/acsinfecdis.6b00080
Handbook on syntheses of amino acids : General routes for the syntheses of amino acids
Blaskovich, Mark A (2010). Handbook on syntheses of amino acids : General routes for the syntheses of amino acids. First ed. New York , NY, U.S.A.: Oxford University Press; American Chemical Society.
Handbook on syntheses of amino acids : General routes for the syntheses of amino acids
Blaskovich, Mark A (2010). Handbook on syntheses of amino acids : General routes for the syntheses of amino acids. First ed. New York , NY, U.S.A.: Oxford University Press; American Chemical Society.
Application of antibiotic-derived fluorescent probes to bacterial studies
Zhang, Bing, Stone, M. Rhia L., Kc, Sanjaya, Łapińska, Urszula, Pagliara, Stefano and Blaskovich, Mark A.T. (2022). Application of antibiotic-derived fluorescent probes to bacterial studies. Methods in enzymology. (pp. 1-28) edited by Erin E. Carlson. San Diego, CA, United States: Academic Press. doi: 10.1016/bs.mie.2021.11.010
Solid-phase synthesis of octapeptin lipopeptides
Hansford, Karl A., Ziora, Zyta M., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Solid-phase synthesis of octapeptin lipopeptides. Peptide synthesis: methods and protocols. (pp. 199-213) edited by Waleed M. Hussein, Mariusz Skwarczynski and Istvan Toth. New York, NY United States: Humana Press. doi: 10.1007/978-1-0716-0227-0_13
Ogunniyi, Abiodun D., Nguyen, Hang Thi, Hansford, Karl A., Cooper, Matthew A., Trott, Darren J. and Blaskovich, Mark A. T. (2023). Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice. Microbiology Spectrum. doi: 10.1128/spectrum.04459-22
The antimicrobial properties of Pd(II)‐ and Ru(II)‐pyta complexes
van Niekerk, Annick, Joseph, M. Cassiem, Kavanagh, Angela, Dinh, Hue, Swarts, Andrew J., Mapolie, Selwyn F., Zuegg, Johannes, Cain, Amy K., Elliott, Alysha G., Blaskovich, Mark A. T. and Frei, Angelo (2023). The antimicrobial properties of Pd(II)‐ and Ru(II)‐pyta complexes. ChemBioChem. doi: 10.1002/cbic.202300247
Antibiotics in the clinical pipeline as of December 2022
Butler, Mark S., Henderson, Ian R., Capon, Robert J. and Blaskovich, Mark A. T. (2023). Antibiotics in the clinical pipeline as of December 2022. The Journal of Antibiotics, 76 (8), 431-473. doi: 10.1038/s41429-023-00629-8
Bojarska, Joanna, Breza, Martin, Remko, Milan, Yuan, Ye, Ziora, Zyta M., Chai, Tsun-Thai, Madura, Izabela D., Kaczmarek, Krzysztof, Blaskovich, Mark A.T. and Wolf, Wojciech M. (2023). A supramolecular self-assembly of peptide-derived compounds via 1,5-disubstituted tetrazole-based supramolecular synthons: An experimental and computational study. Journal of Molecular Structure, 1288 135732, 135732. doi: 10.1016/j.molstruc.2023.135732
Siderophore conjugates to combat antibiotic-resistant bacteria
Rayner, Beth, Verderosa, Anthony D., Ferro, Vito and Blaskovich, Mark A. T. (2023). Siderophore conjugates to combat antibiotic-resistant bacteria. RSC Medicinal Chemistry, 14 (5), 800-822. doi: 10.1039/d2md00465h
Khan, Sadaf Aiman, Jain, Marut, Pant, Kamal Kishore, Ziora, Zyta Maria and Blaskovich, Mark A. T. (2023). Photocatalytic Degradation of Methylparaben Using Green Nanosilver Supported on Reduced Graphene Oxide. Industrial & Engineering Chemistry Research, 62 (17), 6646-6659. doi: 10.1021/acs.iecr.3c00146
Zhang, Bing, Phetsang, Wanida, Stone, M. Rhia L., Kc, Sanjaya, Butler, Mark S., Cooper, Matthew A., Elliott, Alysha G., Łapińska, Urszula, Voliotis, Margaritis, Tsaneva-Atanasova, Krasimira, Pagliara, Stefano and Blaskovich, Mark A. T. (2023). Synthesis of vancomycin fluorescent probes that retain antimicrobial activity, identify Gram-positive bacteria, and detect Gram-negative outer membrane damage. Communications Biology, 6 (1) 409, 1-16. doi: 10.1038/s42003-023-04745-x
Metals to combat antimicrobial resistance
Frei, Angelo, Verderosa, Anthony D., Elliott, Alysha G., Zuegg, Johannes and Blaskovich, Mark A. T. (2023). Metals to combat antimicrobial resistance. Nature Reviews Chemistry, 7 (3), 1-23. doi: 10.1038/s41570-023-00463-4
Use of antiviral agents and other therapies for COVID-19
Blaskovich, Mark A. T. and Verderosa, Anthony D. (2023). Use of antiviral agents and other therapies for COVID-19. Seminars in Respiratory and Critical Care Medicine, 44 (1), 118-129. doi: 10.1055/s-0042-1758837
Natural products as anthelmintics: safeguarding animal health
Salim, Angela A., Butler, Mark S., Blaskovich, Mark A. T., Henderson, Ian R. and Capon, Robert J. (2023). Natural products as anthelmintics: safeguarding animal health. Natural Product Reports. doi: 10.1039/d3np00019b
Gordon, Jason P., Al Taie, Amer, Miller, Ryan L., Dennis, James W., Blaskovich, Mark A. T., Iredell, Jonathan R., Turnidge, John D., Coombs, Geoffrey W., Grolman, David Charles and Youssef, Jacqueline (2023). Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia. Infectious Diseases and Therapy, 12 (7), 1875-1889. doi: 10.1007/s40121-023-00835-9
Nordholt, Niclas, O'Hara, Kate, Resch-Genger, Ute, Blaskovich, Mark A. T., Rühle, Bastian and Schreiber, Frank (2022). A fluorescently labelled quaternary ammonium compound (NBD-DDA) to study resistance mechanisms in bacteria. Frontiers in Microbiology, 13 1023326, 1-13. doi: 10.3389/fmicb.2022.1023326
Leveraging the potential of silver nanoparticles-based materials towards sustainable water treatment
Khan, Sadaf Aiman, Jain, Marut, Pandey, Ashish, Pant, Kamal Kishore, Ziora, Zyta Maria, Blaskovich, Mark A. T., Shetti, Nagaraj P. and Aminabhavi, Tejraj M. (2022). Leveraging the potential of silver nanoparticles-based materials towards sustainable water treatment. Journal of Environmental Management, 319 115675, 115675. doi: 10.1016/j.jenvman.2022.115675
Frei, Angelo, Elliott, Alysha G., Kan, Alex, Dinh, Hue, Bräse, Stefan, Bruce, Alice E., Bruce, Mitchell R., Chen, Feng, Humaidy, Dhirgam, Jung, Nicole, King, A. Paden, Lye, Peter G., Maliszewska, Hanna K., Mansour, Ahmed M., Matiadis, Dimitris, Muñoz, María Paz, Pai, Tsung-Yu, Pokhrel, Shyam, Sadler, Peter J., Sagnou, Marina, Taylor, Michelle, Wilson, Justin J., Woods, Dean, Zuegg, Johannes, Meyer, Wieland, Cain, Amy K., Cooper, Matthew A. and Blaskovich, Mark A. T. (2022). Metal complexes as antifungals? From a crowd-sourced compound library to the first in vivo experiments. JACS Au, 2 (10), 2277-2294. doi: 10.1021/jacsau.2c00308
Ang, Chee Wei, Lee, Brendon M., Jackson, Colin J., Wang, Yuehong, Franzblau, Scott G., Francisco, Amanda F., Kelly, John M., Bernhardt, Paul V., Tan, Lendl, West, Nicholas P., Sykes, Melissa L., Hinton, Alexandra O., Bolisetti, Raghu, Avery, Vicky M., Cooper, Matthew A. and Blaskovich, Mark A.T. (2022). Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection. Journal of Medicinal Chemistry, 65 (19), 13125-13142. doi: 10.1021/acs.jmedchem.2c00972
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381, 1-16. doi: 10.1126/scitranslmed.abj2381
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381. doi: 10.1126/scitranslmed.abj238
Investigations into the membrane activity of arenicin antimicrobial peptide AA139
Edwards, Ingrid A., Henriques, Sónia T., Blaskovich, Mark A.T., Elliott, Alysha G. and Cooper, Matthew A. (2022). Investigations into the membrane activity of arenicin antimicrobial peptide AA139. Biochimica et Biophysica Acta - General Subjects, 1866 (8) 130156, 130156. doi: 10.1016/j.bbagen.2022.130156
Moynihan, Eoin, Mackey, Katrina, Blaskovich, Mark A. T., Reen, F. Jerry and McGlacken, Gerard (2022). N-Alkyl-2-quinolonopyrones demonstrate antimicrobial activity against ESKAPE pathogens including Staphylococcus aureus. ACS Medicinal Chemistry Letters, 13 (8), 1358-1362. doi: 10.1021/acsmedchemlett.2c00185
Fast bacterial growth reduces antibiotic accumulation and efficacy
Łapińska, Urszula, Voliotis, Margaritis, Lee, Ka Kiu, Campey, Adrian, Stone, Rhia M. L., Tuck, Brandon, Phetsang, Wanida, Zhang, Bing, Tsaneva-Atanasova, Krasimira, Blaskovich, Mark A. T. and Pagliara, Stefano (2022). Fast bacterial growth reduces antibiotic accumulation and efficacy. eLife, 11 e74062, 1-33. doi: 10.7554/ELIFE.74062
Hong, Yaoqin, Qin, Jilong, Verderosa, Anthony D., Hawas, Sophia, Zhang, Bing, Blaskovich, Mark A. T., Cronan, John E. and Totsika, Makrina (2022). Loss of β-ketoacyl acyl carrier protein synthase III activity restores multidrug-resistant escherichia coli sensitivity to previously ineffective antibiotics. mSphere, 7 (3), e0011722. doi: 10.1128/msphere.00117-22
Medina-Franco, José L., López-López, Edgar, Andrade, Emma, Ruiz-Azuara, Lena, Frei, Angelo, Guan, Davy, Zuegg, Johannes and Blaskovich, Mark A.T. (2022). Bridging informatics and medicinal inorganic chemistry: toward a database of metallodrugs and metallodrug candidates. Drug Discovery Today, 27 (5), 1420-1430. doi: 10.1016/j.drudis.2022.02.021
Jain, Marut, Khan, Sadaf Aiman, Sahoo, Abhisek, Dubey, Prashant, Pant, Kamal Kishore, Ziora, Zyta Maria and Blaskovich, Mark A.T. (2022). Statistical evaluation of cow-dung derived activated biochar for phenol adsorption: adsorption isotherms, kinetics, and thermodynamic studies. Bioresource Technology, 352 127030, 127030. doi: 10.1016/j.biortech.2022.127030
Hussein, Maytham, Allobawi, Rafah, Levou, Irini, Blaskovich, Mark A. T., Rao, Gauri G., Li, Jian and Velkov, Tony (2022). Mechanisms underlying synergistic killing of Polymyxin B in combination with cannabidiol against Acinetobacter baumannii: a metabolomic study. Pharmaceutics, 14 (4) 786. doi: 10.3390/pharmaceutics14040786
Amino alcohols as potential antibiotic and antifungal leads
Baker, Jennifer R., Cossar, Peter J., Blaskovich, Mark A. T., Elliott, Alysha G., Zuegg, Johannes, Cooper, Matthew A., Lewis, Peter J. and McCluskey, Adam (2022). Amino alcohols as potential antibiotic and antifungal leads. Molecules, 27 (7) 2050. doi: 10.3390/molecules27072050
Nanomaterials: the new antimicrobial magic bullet
Ndayishimiye, John, Kumeria, Tushar, Popat, Amirali, Falconer, James Robert and Blaskovich, Mark A. T. (2022). Nanomaterials: the new antimicrobial magic bullet. ACS Infectious Diseases, 8 (4), 693-712. doi: 10.1021/acsinfecdis.1c00660
Ndayishimiye, John, Kumeria, Tushar, Popat, Amirali, Blaskovich, Mark A.T. and Falconer, James Robert (2022). Understanding the relationship between solubility and permeability of γ-cyclodextrin-based systems embedded with poorly aqueous soluble benznidazole. International Journal of Pharmaceutics, 616 121487, 121487. doi: 10.1016/j.ijpharm.2022.121487
Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents
Skwarczynski, Mariusz, Bashiri, Sahra, Yuan, Ye, Ziora, Zyta M., Nabil, Osama, Masuda, Keita, Khongkow, Mattaka, Rimsueb, Natchanon, Cabral, Horacio, Ruktanonchai, Uracha, Blaskovich, Mark A. T. and Toth, Istvan (2022). Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents. Antibiotics, 11 (3) 412, 412. doi: 10.3390/antibiotics11030412
Blaskovich, Mark (2022). Featured article editorial: discovery of a tricyclic β-lactam active against carbapenem-resistant enterobacterales. ACS Infectious Diseases, 8 (3) acsinfecdis.2c00088, 398-398. doi: 10.1021/acsinfecdis.2c00088
De Oliveira, David M. P., Forde, Brian M., Phan, Minh-Duy, Steiner, Bernhard, Zhang, Bing, Zuegg, Johannes, El-deeb, Ibrahim M., Li, Gen, Keller, Nadia, Brouwer, Stephan, Harbison-Price, Nichaela, Cork, Amanda J., Bauer, Michelle J., Alquethamy, Saleh F., Beatson, Scott A., Roberts, Jason A., Paterson, David L., McEwan, Alastair G., Blaskovich, Mark A. T., Schembri, Mark A., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2022). Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 13 (1) e03517, e0351721. doi: 10.1128/mbio.03517-21
Goodall, Emily C. A., Isom, Georgia L., Rooke, Jessica L., Pullela, Karthik, Icke, Christopher, Yang, Zihao, Boelter, Gabriela, Jones, Alun, Warner, Isabel, Da Costa, Rochelle, Zhang, Bing, Rae, James, Tan, Wee Boon, Winkle, Matthias, Delhaye, Antoine, Heinz, Eva, Collet, Jean-Francois, Cunningham, Adam F., Blaskovich, Mark A., Parton, Robert G., Cole, Jeff A., Banzhaf, Manuel, Chng, Shu-Sin, Vollmer, Waldemar, Bryant, Jack A. and Henderson, Ian R. (2021). Loss of YhcB results in dysregulation of coordinated peptidoglycan, LPS and phospholipid synthesis during Escherichia coli cell growth. PLoS Genetics, 17 (12) e1009586, 1-40. doi: 10.1371/journal.pgen.1009586
Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds
Mirzaee, Hooman, Ariens, Emily, Blaskovich, Mark A. T., Clark, Richard J. and Schenk, Peer M. (2021). Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds. Pharmaceuticals, 14 (12) 1232, 1232. doi: 10.3390/ph14121232
CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage
Conners, Rebecca, McLaren, Mathew, Łapińska, Urszula, Sanders, Kelly, Stone, M. Rhia L., Blaskovich, Mark A. T., Pagliara, Stefano, Daum, Bertram, Rakonjac, Jasna and Gold, Vicki A. M. (2021). CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage. Nature Communications, 12 (1) 6316, 6316. doi: 10.1038/s41467-021-26610-3
Jain, Marut, Khan, Sadaf Aiman, Pandey, Ashish, Pant, Kamal Kishore, Ziora, Zyta Maria and Blaskovich, Mark A.T. (2021). Instructive analysis of engineered carbon materials for potential application in water and wastewater treatment. Science of The Total Environment, 793 148583, 1-19. doi: 10.1016/j.scitotenv.2021.148583
Zhang, Chen, Lum, Kah Yean, Taki, Aya C., Gasser, Robin B., Byrne, Joseph J., Wang, Tao, Blaskovich, Mark A.T., Register, Emery T., Montaner, Luis J., Tietjen, Ian and Davis, Rohan A. (2021). Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold. Phytochemistry, 190 112887, 1-10. doi: 10.1016/j.phytochem.2021.112887
Bettoni, Serena, Maziarz, Karolina, Stone, M. Rhia L., Blaskovich, Mark A. T., Potempa, Jan, Bazzo, Maria Luiza, Unemo, Magnus, Ram, Sanjay and Blom, Anna M. (2021). Serum complement activation by C4BP-IgM fusion protein can restore susceptibility to antibiotics in Neisseria gonorrhoeae. Frontiers in Immunology, 12 726801, 1-15. doi: 10.3389/fimmu.2021.726801
Mesoporous silica nanoparticles improve oral delivery of antitubercular bicyclic nitroimidazoles
Ang, Chee Wei, Tan, Lendl, Qu, Zhi, West, Nicholas P., Cooper, Matthew A., Popat, Amirali and Blaskovich, Mark A.T. (2021). Mesoporous silica nanoparticles improve oral delivery of antitubercular bicyclic nitroimidazoles. ACS Biomaterials Science and Engineering, 8 (10) acsbiomaterials.1c00807, 4196-4206. doi: 10.1021/acsbiomaterials.1c00807
Antibiotic alternatives special issue
Blaskovich, Mark A. T. (2021). Antibiotic alternatives special issue. ACS Infectious Diseases, 7 (8), 2025-2026. doi: 10.1021/acsinfecdis.1c00388
Targeted protein degradation: the new frontier of antimicrobial discovery?
Powell, Matthew, Blaskovich, Mark A. T. and Hansford, Karl A. (2021). Targeted protein degradation: the new frontier of antimicrobial discovery?. ACS Infectious Diseases, 7 (8) acsinfecdis.1c00203, 2050-2067. doi: 10.1021/acsinfecdis.1c00203
Antimicrobial screening of a historical collection of over 140 000 small molecules
Semenov, Victor V., Raihstat, Mikhail M., Konyushkin, Leonid D., Semenov, Roman V., Blaskovich, Mark A. T., Zuegg, Johannes, Elliott, Alysha G., Hansford, Karl A. and Cooper, Matthew A. (2021). Antimicrobial screening of a historical collection of over 140 000 small molecules. Mendeleev Communications, 31 (4), 484-487. doi: 10.1016/j.mencom.2021.07.015
Michael, Carolyn A., Gillings, Michael R., Blaskovich, Mark A. T. and Franks, Ashley E. (2021). The antimicrobial resistance crisis: an inadvertent, unfortunate but nevertheless informative experiment in evolutionary biology. Frontiers in Ecology and Evolution, 9 692674. doi: 10.3389/fevo.2021.692674
Chemical synthesis of TFF3 reveals novel mechanistic insights and a gut-stable metabolite
Braga Emidio, Nayara, Meli, Rajeshwari, Tran, Hue N. T., Baik, Hayeon, Morisset-Lopez, Séverine, Elliott, Alysha G., Blaskovich, Mark A. T., Spiller, Sabrina, Beck-Sickinger, Annette G., Schroeder, Christina I. and Muttenthaler, Markus (2021). Chemical synthesis of TFF3 reveals novel mechanistic insights and a gut-stable metabolite. Journal of Medicinal Chemistry, 64 (13) acs.jmedchem.1c00767, 9484-9495. doi: 10.1021/acs.jmedchem.1c00767
There is no market for new antibiotics: this allows an open approach to research and development
Klug, Dana M., Idiris, Fahima I. M., Blaskovich, Mark A. T., von Delft, Frank, Dowson, Christopher G., Kirchhelle, Claas, Roberts, Adam P., Singer, Andrew C. and Todd, Matthew H. (2021). There is no market for new antibiotics: this allows an open approach to research and development. Wellcome Open Research, 6 146, 146. doi: 10.12688/wellcomeopenres.16847.1
Virtual Issue: Anti-infective Discovery Down Under
Blaskovich, Mark (2021). Virtual Issue: Anti-infective Discovery Down Under. ACS Infectious Diseases, 7 (6), 1555-1557. doi: 10.1021/acsinfecdis.1c00196
Cho, Hye-Kyung, Karau, Melissa J., Greenwood-Quaintance, Kerryl E., Hansford, Karl A., Cooper, Matthew A., Blaskovich, Mark A. T. and Patel, Robin (2021). In Vitro activity of vancapticin MCC5145 against methicillin-resistant Staphylococcus aureus from periprosthetic joint infection. Antimicrobial Agents and Chemotherapy, 65 (5) e02443-20. doi: 10.1128/aac.02443-20
Muller, Jessica A. I., Lawrence, Nicole, Chan, Lai Yue, Harvey, Peta J., Elliott, Alysha G., Blaskovich, Mark A. T., Gonçalves, Jacqueline C., Galante, Priscilla, Mortari, Marcia R., Toffoli-Kadri, Mônica C., Koehbach, Johannes and Craik, David (2021). Antimicrobial and anticancer properties of synthetic peptides derived from the wasp Parachartergus fraternus. Chembiochem , 22 (8) cbic.202000716, 1415-1423. doi: 10.1002/cbic.202000716
Ul Bari, Wasim, Ur Rehman, Najeeb, Khan, Ajmal, Ahsan Halim, Sobia, Yuan, Ye, Blaskovich, Mark A.T., Ziora, Zyta M., Zahoor, Muhammad, Naz, Sumaira, Ullah, Riaz, Alotaibi, Amal and Al-Harrasi, Ahmed (2021). Bio-potency and molecular docking studies of isolated compounds from Grewia optiva J.R. Drumm. ex Burret. Molecules, 26 (7) 2019, 2019. doi: 10.3390/molecules26072019
Ndayishimiye, John, Popat, Amirali, Kumeria, Tushar, Blaskovich, Mark A.T. and Falconer, James Robert (2021). Supercritical carbon dioxide assisted complexation of benznidazole: γ-cyclodextrin for improved dissolution. International Journal of Pharmaceutics, 596 120240, 120240. doi: 10.1016/j.ijpharm.2021.120240
Frei, Angelo, King, A. Paden, Lowe, Gabrielle J., Cain, Amy K., Short, Francesca L., Dinh, Hue, Elliott, Alysha G., Zuegg, Johannes, Wilson, Justin J. and Blaskovich, Mark A. T. (2021). Cover feature: nontoxic cobalt(III) schiff base complexes with broad‐spectrum antifungal activity (Chem. Eur. J. 6/2021). Chemistry – A European Journal, 27 (6), 1861-1861. doi: 10.1002/chem.202004912
Nontoxic cobalt(III) schiff base complexes with broad‐spectrum antifungal activity
Frei, Angelo, King, A. Paden, Lowe, Gabrielle J., Cain, Amy K., Short, Francesca L., Dinh, Hue, Elliott, Alysha G., Zuegg, Johannes, Wilson, Justin J. and Blaskovich, Mark A. T. (2021). Nontoxic cobalt(III) schiff base complexes with broad‐spectrum antifungal activity. Chemistry – A European Journal, 27 (6), 2021-2029. doi: 10.1002/chem.202003545
The antimicrobial potential of cannabidiol
Blaskovich, Mark A. T., Kavanagh, Angela M., Elliott, Alysha G., Zhang, Bing, Ramu, Soumya, Amado, Maite, Lowe, Gabrielle J., Hinton, Alexandra O., Pham, Do Minh Thu, Zuegg, Johannes, Beare, Neil, Quach, Diana, Sharp, Marc D., Pogliano, Joe, Rogers, Ashleigh P., Lyras, Dena, Tan, Lendl, West, Nicholas P., Crawford, David W., Peterson, Marnie L., Callahan, Matthew and Thurn, Michael (2021). The antimicrobial potential of cannabidiol. Communications Biology, 4 (1) 7, 1-18. doi: 10.1038/s42003-020-01530-y
Omer, Ahmed M., Ziora, Zyta M., Tamer, Tamer M., Khalifa, Randa E., Hassan, Mohamed A., Mohy-Eldin, Mohamed S. and Blaskovich, Mark A. T. (2021). Formulation of quaternized aminated chitosan nanoparticles for efficient encapsulation and slow eelease of curcumin. Molecules, 26 (2) 449, 1-14. doi: 10.3390/molecules26020449
Jain, Marut, Khan, Sadaf Aiman, Sharma, Komal, Jadhao, Prashant Ram, Pant, Kamal Kishore, Ziora, Zyta Maria and Blaskovich, Mark A.T. (2021). Current perspective of innovative strategies for bioremediation of organic pollutants from wastewater. Bioresource Technology, 344 (Pt B) 126305, 126305. doi: 10.1016/j.biortech.2021.126305
Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin
Ndayishimiye, John, Cao, Yuxue, Kumeria, Tushar, Blaskovich, Mark A. T., Falconer, James Robert and Popat, Amirali (2021). Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin. Journal of Materials Chemistry B, 9 (35), 7145-7166. doi: 10.1039/d1tb01430g
Platinum cyclooctadiene complexes with activity against gram-positive bacteria
Frei, Angelo, Ramu, Soumya, Lowe, Gabrielle J., Dinh, Hue, Semenec, Lucie, Elliott, Alysha G., Zuegg, Johannes, Deckers, Anke, Jung, Nicole, Bräse, Stefan, Cain, Amy K. and Blaskovich, Mark A. T. (2021). Platinum cyclooctadiene complexes with activity against gram-positive bacteria. ChemMedChem, 16 (20) cmdc.202100157, 1-8. doi: 10.1002/cmdc.202100157
Syzygium cumini(L.),Skeels fruit extracts: in vitro and in vivo anti-inflammatory properties
Qamar, Muhammad, Akhtar, Saeed, Ismail, Tariq, Yuan, Ye, Ahmad, Naveed, Tawab, Abdul, Ismail, Amir, Barnard, Ross T., Cooper, Matthew A., Blaskovich, Mark.A.T. and Ziora, Zyta M. (2021). Syzygium cumini(L.),Skeels fruit extracts: in vitro and in vivo anti-inflammatory properties. Journal of Ethnopharmacology, 271 113805, 1-12. doi: 10.1016/j.jep.2021.113805
Multi-institution research and education collaboration identifies new antimicrobial compounds
Fuller, Amelia A., Dounay, Amy B., Schirch, Douglas, Rivera, Daniel G., Hansford, Karl A., Elliott, Alysha G., Zuegg, Johannes, Cooper, Matthew A., Blaskovich, Mark A. T., Hitchens, Jacob R., Burris-Hiday, Sarah, Tenorio, Kristiana, Mendez, Yanira, Samaritoni, J. Geno, O’Donnell, Martin J. and Scott, William L. (2020). Multi-institution research and education collaboration identifies new antimicrobial compounds. ACS Chemical Biology, 15 (12), 3187-3196. doi: 10.1021/acschembio.0c00732
De Oliveira, David M. P., Bohlmann, Lisa, Conroy, Trent, Jen, Freda E.-C., Everest-Dass, Arun, Hansford, Karl A., Bolisetti, Raghu, El-Deeb, Ibrahim M., Forde, Brian M., Phan, Minh-Duy, Lacey, Jake A., Tan, Aimee, Rivera-Hernandez, Tania, Brouwer, Stephan, Keller, Nadia, Kidd, Timothy J., Cork, Amanda J., Bauer, Michelle J., Cook, Gregory M., Davies, Mark R., Beatson, Scott A., Paterson, David L., McEwan, Alastair G., Li, Jian, Schembri, Mark A., Blaskovich, Mark A. T., Jennings, Michael P., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2020). Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Science Translational Medicine, 12 (570) abb3791, eabb3791. doi: 10.1126/scitranslmed.abb3791
Call for Papers: Antibiotic Alternatives Special Issue
Blaskovich, Mark. A. T. (2020). Call for Papers: Antibiotic Alternatives Special Issue. ACS Infectious Diseases, 6 (11), 2812-2812. doi: 10.1021/acsinfecdis.0c00663
Ndayishimiye, John, Popat, Amirali, Blaskovich, Mark and Falconer, James Robert (2020). Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides. Journal of Controlled Release, 324, 728-749. doi: 10.1016/j.jconrel.2020.05.002
Braga Emidio, Nayara, Baik, Hayeon, Lee, David, Stürmer, René, Heuer, Jörn, Elliott, Alysha G, Blaskovich, Mark A T, Haupenthal, Katharina, Tegtmeyer, Nicole, Hoffmann, Werner, Schroeder, Christina I and Muttenthaler, Markus (2020). Correction: Chemical synthesis of human trefoil factor 1 (TFF1) and its homodimer provides novel insights into their mechanisms of action. Chemical communications (Cambridge, England), 56 (51), 7049-7049. doi: 10.1039/d0cc90250k
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
Elliott, Alysha G., Huang, Johnny X., Neve, Søren, Zuegg, Johannes, Edwards, Ingrid A., Cain, Amy K., Boinett, Christine J., Barquist, Lars, Lundberg, Carina Vingsbo, Steen, Jason, Butler, Mark S., Mobli, Mehdi, Porter, Kaela M., Blaskovich, Mark A. T., Lociuro, Sergio, Strandh, Magnus and Cooper, Matthew A. (2020). An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. Nature Communications, 11 (1) 3184, 3184. doi: 10.1038/s41467-020-16950-x
Antibiotics special issue: Challenges and opportunities in antibiotic discovery and development
Blaskovich, Mark A. T. (2020). Antibiotics special issue: Challenges and opportunities in antibiotic discovery and development. ACS Infectious Diseases, 6 (6), 1286-1288. doi: 10.1021/acsinfecdis.0c00331
How to stimulate and facilitate early stage antibiotic discovery
Zuegg, Johannes, Hansford, Karl A., Elliott, Alysha G., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). How to stimulate and facilitate early stage antibiotic discovery. ACS Infectious Diseases, 6 (6), 1302-1304. doi: 10.1021/acsinfecdis.0c00163
Correction: Metal complexes as a promising source for new antibiotics (vol 11, pg 2627, 2020)
Frei, Angelo, Zuegg, Johannes, Elliott, Alysha G., Baker, Murray, Braese, Stefan, Brown, Christopher, Chen, Feng, Dowson, Christopher G., Dujardin, Gilles, Jung, Nicole, King, A. Paden, Mansour, Ahmed M., Massi, Massimiliano, Moat, John, Mohamed, Heba A., Renfrew, Anna K., Rutledge, Peter J., Sadler, Peter J., Todd, Matthew H., Willans, Charlotte E., Wilson, Justin J., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Correction: Metal complexes as a promising source for new antibiotics (vol 11, pg 2627, 2020). Chemical Science, 11 (17), 4531-4531. doi: 10.1039/d0sc90075c
Rineh, Ardeshir, Soren, Odel, McEwan, Timothy, Ravikumar, Vikashini, Poh, Wee Han, Azamifar, Fereshteh, Naimi-Jamal, M. Reza, Cheung, Chen-Yi, Elliott, Alysha G., Zuegg, Johannes, Blaskovich, Mark A. T., Cooper, Matthew A., Dolange, Victoria, Christodoulides, Myron, Cook, Gregory M., Rice, Scott A., Faust, Saul N., Webb, Jeremy S. and Kelso, Michael J. (2020). Discovery of cephalosporin-3′-diazeniumdiolates that show dual antibacterial and antibiofilm effects against Pseudomonas aeruginosa clinical cystic fibrosis isolates and efficacy in a murine respiratory infection model. ACS Infectious Diseases, 6 (6) acsinfecdis.0c00070, 1460-1479. doi: 10.1021/acsinfecdis.0c00070
Complete genome sequences of clinical Pandoraea fibrosis isolates
Pitt, Miranda E., Nguyen, Son H., Duarte, Tânia P. S., Roddam, Louise F., Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2020). Complete genome sequences of clinical Pandoraea fibrosis isolates. Microbiology Resource Announcements, 9 (13) e00060-20. doi: 10.1128/mra.00060-20
Metal complexes as a promising source for new antibiotics
Frei, Angelo, Zuegg, Johannes, Elliott, Alysha G., Baker, Murray V., Braese, Stefan, Brown, Christopher, Chen, Feng, Dowson, Christopher Gerard, Dujardin, Gilles, Jung, Nicole, King, A. Paden, Mansour, Ahmed Moustafa, Massi, Massimiliano, Moat, John, Mohamed, Heba A., Renfrew, Anna, Rutledge, Peter, Sadler, Peter J., Todd, Matthew Houghton, Willans, Charlotte E., Wilson, Justin Jeff, Cooper, Matthew Allister and Blaskovich, Mark (2020). Metal complexes as a promising source for new antibiotics. Chemical Science, 11 (10), 2627-2639. doi: 10.1039/c9sc06460e
Light-activated rhenium complexes with dual mode of action against bacteria
Frei, Angelo, Amado, Maite, Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Light-activated rhenium complexes with dual mode of action against bacteria. Chemistry: A European Journal, 26 (13) chem.201904689, 2762-2762. doi: 10.1002/chem.201904689
Visualization of bacterial resistance using fluorescent antibiotic probes
Stone, M. Rhia L., Phetsang, Wanida, Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Visualization of bacterial resistance using fluorescent antibiotic probes. Journal of Visualized Experiments, 2020 (157) e60743. doi: 10.3791/60743
Pitt, Miranda E., Nguyen, Son H., Duarte, Tânia P. S., Teng, Haotian, Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2020). Evaluating the genome and resistome of extensively drug-resistant Klebsiella pneumoniae using native DNA and RNA Nanopore sequencing. GigaScience, 9 (2), 1-14. doi: 10.1093/gigascience/giaa002
Sanjaya, K.C., Ranzoni, Andrea, Hung, Jacky, Blaskovich, Mark A.T., Watterson, Daniel, Young, Paul R. and Cooper, Matthew A. (2020). Flow-cytometry detection of fluorescent magnetic nanoparticle clusters increases sensitivity of dengue immunoassay. Analytica Chimica Acta, 1107, 85-91. doi: 10.1016/j.aca.2020.02.007
Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility
Ang, Chee Wei, Tan, Lendl, Sykes, Melissa L., Abugharbiyeh, Neda, Debnath, Anjan, Reid, Janet C., West, Nicholas P., Avery, Vicky M., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility. Journal of Medicinal Chemistry, 63 (24), 15726-15751. doi: 10.1021/acs.jmedchem.0c01372
Braga Emidio, Nayara, Baik, Hayeon, Lee, David, Stürmer, René, Heuer, Jörn, Elliott, Alysha G., Blaskovich, Mark A. T., Haupenthal, Katharina, Tegtmeyer, Nicole, Hoffmann, Werner, Schroeder, Christina I. and Muttenthaler, Markus (2020). Chemical synthesis of human trefoil factor 1 (TFF1) and its homodimer provides novel insights into their mechanisms of action. Chemical Communications, 56 (47), 6420-6423. doi: 10.1039/d0cc02321c
Fluorescent macrolide probes – synthesis and use in evaluation of bacterial resistance
Stone, M. Rhia L., Łapińska, Urszula, Pagliara, Stefano, Masi, Muriel, Blanchfield, Joanne T., Cooper, Matthew A. and Blaskovich, Mark A. T. (2020). Fluorescent macrolide probes – synthesis and use in evaluation of bacterial resistance. RSC Chemical Biology, 1 (5), 395-404. doi: 10.1039/d0cb00118j
Nazir, Yasir, Saeed, Aamer, Rafiq, Muhammad, Afzal, Samina, Ali, Anser, Latif, Muhammad, Zuegg, Johannes, Hussein, Waleed M., Fercher, Christian, Barnard, Ross T., Cooper, Matthew A., Blaskovich, Mark A.T., Ashraf, Zaman and Ziora, Zyta M. (2020). Hydroxyl substituted benzoic acid/cinnamic acid derivatives: tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies. Bioorganic and Medicinal Chemistry Letters, 30 (1) 126722, 1-5. doi: 10.1016/j.bmcl.2019.126722
Non-antibiotic small-molecule regulation of DHFR-based destabilizing domains in vivo
Peng, Hui, Chau, Viet Q., Phetsang, Wanida, Sebastian, Rebecca M., Stone, M. Rhia L., Datta, Shyamtanu, Renwick, Marian, Tamer, Yusuf T., Toprak, Erdal, Koh, Andrew Y., Blaskovich, Mark A.T. and Hulleman, John D. (2019). Non-antibiotic small-molecule regulation of DHFR-based destabilizing domains in vivo. Molecular Therapy - Methods and Clinical Development, 15, 27-39. doi: 10.1016/j.omtm.2019.08.002
Tyrosinase inhibitors as potential antibacterial agents
Yuan, Ye, Jin, Wanli, Nazir, Yasir, Fercher, Christian, Thomas Blaskovich, Mark A., Cooper, Matthew A., Barnard, Ross T. and Ziora, Zyta M. (2019). Tyrosinase inhibitors as potential antibacterial agents. European Journal of Medicinal Chemistry, 187 111892, 111892. doi: 10.1016/j.ejmech.2019.111892
Brown, Peter, Tan, Aik-Choon, El-Esawi, Mohamed A., Liehr, Thomas, Blanck, Oliver, Gladue, Douglas P., Almeida, Gabriel M. F., Cernava, Tomislav, Sorzano, Carlos O., Yeung, Andy W. K., Engel, Michael S., Chandrasekaran, Arun Richard, Muth, Thilo, Staege, Martin S., Daulatabad, Swapna V., Widera, Darius, Zhang, Junpeng, Meule, Adrian, Honjo, Ken, Pourret, Olivier, Yin, Cong-Cong, Zhang, Zhongheng, Cascella, Marco, Flegel, Willy A., Goodyear, Carl S., van Raaij, Mark J., Bukowy-Bieryllo, Zuzanna, Campana, Luca G., Kurniawan, Nicholas A. ... RELISH Consortium (2019). Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database-The Journal of Biological Databases and Curation, 2019, 1-67. doi: 10.1093/database/baz085
In vitro antimicrobial activity of acne drugs against skin-associated bacteria
Blaskovich, Mark A. T., Elliott, Alysha G., Kavanagh, Angela M., Ramu, Soumya and Cooper, Matthew A. (2019). In vitro antimicrobial activity of acne drugs against skin-associated bacteria. Scientific Reports, 9 (1) 14658, 14658. doi: 10.1038/s41598-019-50746-4
Call for Papers: Antibiotics Special Issue
Blaskovich, Mark A. T. (2019). Call for Papers: Antibiotics Special Issue. ACS Infectious Diseases, 5 (8) acsinfecdis.0c00663, 1264-1264. doi: 10.1021/acsinfecdis.9b00262
Elucidating the lipid binding properties of membrane-active peptides using cyclised nanodiscs
Zhang, Alan H., Edwards, Ingrid A., Mishra, Biswa P., Sharma, Gagan, Healy, Michael D., Elliott, Alysha, Blaskovich, Mark A. T., Cooper, Matthew A., Collins, Brett M., Jia, Xinying and Mobli, Mehdi (2019). Elucidating the lipid binding properties of membrane-active peptides using cyclised nanodiscs. Frontiers in Chemistry, 7 (MAR) 238, 238. doi: 10.3389/fchem.2019.00238
The eagle effect and antibiotic-induced persistence: two sides of the same coin?
Prasetyoputri, Anggia, Jarrad, Angie M., Cooper, Matthew A. and Blaskovich, Mark A.T. (2019). The eagle effect and antibiotic-induced persistence: two sides of the same coin?. Trends in Microbiology, 27 (4), 339-354. doi: 10.1016/j.tim.2018.10.007
Structure-function studies of polymyxin B lipononapeptides
Gallardo-Godoy, Alejandra, Hansford, Karl, Muldoon, Craig, Becker, Bernd, Elliott, Alysha, Huang, Johnny, Pelingon, Ruby, Butler, Mark, Blaskovich, Mark and Cooper, Matthew (2019). Structure-function studies of polymyxin B lipononapeptides. Molecules, 24 (3) 553, 553. doi: 10.3390/molecules24030553
Effects of microplate type and broth additives on microdilution MIC susceptibility assays
Kavanagh, Angela, Ramu, Soumya, Gong, Yujing, Cooper, Matthew A. and Blaskovich, Mark A. T. (2019). Effects of microplate type and broth additives on microdilution MIC susceptibility assays. Antimicrobial Agents and Chemotherapy, 63 (1) e01760-18. doi: 10.1128/aac.01760-18
Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux
Stone, M. Rhia L., Masi, Muriel, Phetsang, Wanida, Pagès, Jean-Marie, Cooper, Matthew A. and Blaskovich, Mark A. T. (2019). Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux. MedChemComm, 10 (6), 901-906. doi: 10.1039/c9md00124g
Pham, Thu D. M., Ziora, Zyta M. and Blaskovich, Mark A. T. (2019). Quinolone antibiotics. MedChemComm, 10 (10), 1719-1739. doi: 10.1039/c9md00120d
The diminished antimicrobial pipeline
Blaskovich, Mark A.T. (2019). The diminished antimicrobial pipeline. Microbiology Australia, 40 (2), 92-96. doi: 10.1071/MA19025
Jarrad, Angie M., Ang, Chee Wei, Debnath, Anjan, Hahn, Hye Jee, Woods, Kyra, Tan, Lendl, Sykes, Melissa L., Jones, Amy J., Pelingon, Ruby, Butler, Mark S., Avery, Vicky M., West, Nicholas P., Karoli, Tomislav, Blaskovich, Mark A. T. and Cooper, Matthew A. (2018). Design, synthesis and biological evaluation of 2-nitroimidazopyrazin-one/-es with antitubercular and antiparasitic activity. Journal of Medicinal Chemistry, 61 (24) acs.jmedchem.8b01578, 11349-11371. doi: 10.1021/acs.jmedchem.8b01578
Pitt, Miranda E., Cao, Minh Duc, Butler, Mark S., Ramu, Soumya, Ganesamoorthy, Devika, Blaskovich, Mark A. T., Coin, Lachlan J. M. and Cooper, Matthew A. (2018). Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate. The Journal of Antimicrobial Chemotherapy, 74 (3), 582-593. doi: 10.1093/jac/dky458
Sim, Wilson, Barnard, Ross, Blaskovich, M.A.T. and Ziora, Zyta (2018). Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017). Antibiotics, 7 (4) 93, 93. doi: 10.3390/antibiotics7040093
Silver bullets: a new lustre on an old antimicrobial agent
Möhler, Jasper S., Sim, Wilson, Blaskovich, Mark A. T., Cooper, Matthew A. and Ziora, Zyta M. (2018). Silver bullets: a new lustre on an old antimicrobial agent. Biotechnology Advances, 36 (5), 1391-1411. doi: 10.1016/j.biotechadv.2018.05.004
Jarrad, Angie M., Blaskovich, Mark A. T., Prasetyoputri, Anggia, Karoli, Tomislav, Hansford, Karl A. and Cooper, Matthew A. (2018). Detection and investigation of Eagle effect resistance to vancomycin in Clostridium difficile with an ATP-bioluminescence assay. Frontiers in Microbiology, 9 (JUL) 1420, 1420. doi: 10.3389/fmicb.2018.01420
Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich, Mark A. T., Pitt, Miranda E., Elliott, Alysha G. and Cooper, Matthew A. (2018). Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?. Expert Review of Anti-infective Therapy, 16 (6), 485-499. doi: 10.1080/14787210.2018.1483240
The fight against antimicrobial resistance is confounded by a global increase in antibiotic usage
Blaskovich, Mark A. T. (2018). The fight against antimicrobial resistance is confounded by a global increase in antibiotic usage. ACS Infectious Diseases, 4 (6), 868-870. doi: 10.1021/acsinfecdis.8b00109
Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance
Stone, M Rhia L., Butler, Mark S., Phetsang, Wanida, Cooper, Matthew A. and Blaskovich, Mark A. T. (2018). Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance. Trends in Biotechnology, 36 (5), 523-536. doi: 10.1016/j.tibtech.2018.01.004
Pitt, Miranda E., Elliott, Alysha G., Cao, Minh Duc, Ganesamoorthy, Devika, Karaiskos, Ilias, Giamarellou, Helen, Abboud, Cely S., Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2018). Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microbial Genomics, 4 (3) 000158. doi: 10.1099/mgen.0.000158
Velkov, Tony, Gallardo-Godoy, Alejandra, Swarbrick, James D., Blaskovich, Mark A. T., Elliott, Alysha G., Han, Meiling, Thompson, Philip E., Roberts, Kade D., Huang, Johnny X., Becker, Bernd, Butler, Mark S., Lash, Lawrence H., Henriques, Sónia Troeira, Nation, Roger L., Sivanesan, Sivashangarie, Sani, Marc-Antoine, Separovic, Frances, Mertens, Haydyn, Bulach, Dieter, Seemann, Torsten, Owen, Jeremy, Li, Jian and Cooper, Matthew A. (2018). Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria. Cell Chemical Biology, 25 (4), 380-391.e5. doi: 10.1016/j.chembiol.2018.01.005
Developments in Glycopeptide Antibiotics
Blaskovich, Mark A. T., Hansford, Karl A., Butler, Mark S., Jia, ZhiGuang, Mark, Alan E. and Cooper, Matthew A. (2018). Developments in Glycopeptide Antibiotics. ACS Infectious Diseases, 4 (5), 715-735. doi: 10.1021/acsinfecdis.7b00258
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
Blaskovich, Mark A T, Hansford, Karl A., Gong, Yujing, Butler, Mark S., Muldoon, Craig, Huang, Johnny X., Ramu, Soumya, Silva, Alberto B., Cheng, Mu, Kavanagh, Angela M., Ziora, Zyta, Premraj, Rajaratnam, Lindahl, Fredrik, Bradford, Tanya A., Lee, June C., Karoli, Tomislav, Pelingon, Ruby, Edwards, David J., Amado, Maite, Elliott, Alysha G, Phetsang, Wanida, Daud, Noor Huda, Deecke, Johan E, Sidjabat, Hanna E, Ramaologa, Sefetogi, Zuegg, Johannes, Betley, Jason R, Beevers, Andrew P G, Smith, Richard A G ... Cooper, Matthew A. (2018). Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Nature Communications, 9 (1) 02123, 22. doi: 10.1038/s41467-017-02123-w
Paparella, Ashleigh S., Feng, Jiage, Blanco-Rodriguez, Beatriz, Feng, Zikai, Phetsang, Wanida, Blaskovich, Mark A. T., Cooper, Matthew A., Booker, Grant W., Polyak, Steven W. and Abell, Andrew D. (2017). A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase. Tetrahedron, 74 (12), 1175-1183. doi: 10.1016/j.tet.2017.10.032
Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1
Edwards, Ingrid A, Elliott, Alysha G, Kavanagh, Angela M, Blaskovich, Mark A T and Cooper, Matthew A (2017). Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1. ACS infectious diseases, 3 (12), 917-926. doi: 10.1021/acsinfecdis.7b00123
Nitroimidazoles: Molecular fireworks that combat a broad spectrum of infectious diseases
Ang, Chee Wei, Jarrad, Angie M., Cooper, Matthew A. and Blaskovich, Mark A. T. (2017). Nitroimidazoles: Molecular fireworks that combat a broad spectrum of infectious diseases. Journal of Medicinal Chemistry, 60 (18), 7636-7657. doi: 10.1021/acs.jmedchem.7b00143
Investigating the interaction of octapeptin A3 with model bacterial membranes
Han, Mei-Ling, Shen, Hsin-Hui, Hansford, Karl A., Schneider, Elena K., Sivanesan, Sivashangarie, Roberts, Kade D., Thompson, Philip E., Le Brun, Anton P., Zhu, Yan, Sani, Marc-Antoine, Separovic, Frances, Blaskovich, Mark A. T., Baker, Mark A., Moskowitz, Samuel M., Cooper, Matthew A., Li, Jian and Velkov, Tony (2017). Investigating the interaction of octapeptin A3 with model bacterial membranes. ACS Infectious Diseases, 3 (8), 606-619. doi: 10.1021/acsinfecdis.7b00065
Hussein, Maytham H., Schneider, Elena K., Elliott, Alysha G., Han, Meiling, Reyes-Ortega, Felisa, Morris, Faye, Blaskovich, Mark A. T., Jasim, Raad, Currie, Bart, Mayo, Mark, Baker, Mark, Cooper, Matthew A., Li, Jian and Velkov, Tony (2017). From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Microbial Drug Resistance, 23 (5), 640-650. doi: 10.1089/mdr.2016.0196
Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria
Becker, Bernd, Butler, Mark S., Hansford, Karl A., Gallardo-Godoy, Alejandra, Elliott, Alysha G., Huang, Johnny X., Edwards, David J., Blaskovich, Mark A. T. and Cooper, Matthew A. (2017). Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria. Bioorganic and Medicinal Chemistry Letters, 27 (11), 2407-2409. doi: 10.1016/j.bmcl.2017.04.027
Desselle, Mathilde R., Neale, Ruth, Hansford, Karl A., Zuegg, Johannes, Elliott, Alysha G., Cooper, Matthew A. and Blaskovich, Mark A. T. (2017). Institutional profile: Community for Open Antimicrobial Drug Discovery - crowdsourcing new antibiotics and antifungals. Future Science OA, 3 (2) FSO171, FSO171. doi: 10.4155/fsoa-2016-0093
Polishing the tarnished silver bullet: the quest for new antibiotics
Blaskovich, Mark A. T., Butler, Mark S. and Cooper, Matthew A. (2017). Polishing the tarnished silver bullet: the quest for new antibiotics. Antimicrobial Resistance, 61 (1), 103-114. doi: 10.1042/EBC20160077
Möhler, Jasper S., Kolmar, Theresa, Synnatschke, Kevin, Hergert, Marcel, Wilson, Liam A., Ramu, Soumya, Elliott, Alysha G., Blaskovich, Mark A.T., Sidjabat, Hanna E., Paterson, David L., Schenk, Gerhard, Cooper, Matthew A. and Ziora, Zyta M. (2017). Enhancement of antibiotic-activity through complexation with metal ions - Combined ITC, NMR, enzymatic and biological studies. Journal of Inorganic Biochemistry, 167, 134-141. doi: 10.1016/j.jinorgbio.2016.11.028
Unusual amino acids in medicinal chemistry
Blaskovich, Mark A. T. (2016). Unusual amino acids in medicinal chemistry. Journal of Medicinal Chemistry, 59 (24), 10807-10836. doi: 10.1021/acs.jmedchem.6b00319
Hassan, Marwa Hussain Ali, Ranzoni, Andrea, Phetsang, Wanida, Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Surface ligand density of antibiotic-nanoparticle conjugates enhances target avidity and membrane permeabilization of vancomycin-resistant bacteria. Bioconjugate Chemistry, 28 (2), 353-361. doi: 10.1021/acs.bioconjchem.6b00494
Old dogs and new tricks in antimicrobial discovery
Butler, Mark, Blaskovich, Mark, Owen, Jeremy G. and Cooper, Matthew (2016). Old dogs and new tricks in antimicrobial discovery. Current Opinion in Microbiology, 33, 25-34. doi: 10.1016/j.mib.2016.05.011
Jarrad, A. M., Debnath, A., Miyamoto, Y., Hansford, K. A., Pelingon, R., Butler, M. S., Bains, T., Karoli, T., Blaskovich, M. A. T., Eckmann, L. and Cooper, M. A. (2016). Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. European Journal of Medicinal Chemistry, 120, 353-362. doi: 10.1016/j.ejmech.2016.04.064
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling
Croker, Daniel E., Monk, Peter N., Halai, Reena, Kaeslin, Geraldine, Schofield, Zoe, Wu, Mike C. L., Clark, Richard J., Blaskovich, Mark A. T., Morikis, Dimitrios, Floudas, Christodoulos A., Cooper, Matthew and Woodruff, Trent M. (2016). Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling. Immunology and Cell Biology, 94 (8), 787-795. doi: 10.1038/icb.2016.43
Antibiotics in the clinical pipeline at the end of 2015
Butler, Mark S., Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Antibiotics in the clinical pipeline at the end of 2015. The Journal of Antibiotics, 70 (1), 1-22. doi: 10.1038/ja.2016.72
Chemical philanthropy: a path forward for antibiotic discovery?
Hansford, Karl A., Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Chemical philanthropy: a path forward for antibiotic discovery?. Future Medicinal Chemistry, 8 (9), 925-929. doi: 10.4155/fmc-2016-0029
Azmi, Fazren, Elliott, Alysha G., Marasini, Nirmal, Ramu, Soumya, Ziora, Zyta, Kavanagh, Angela M., Blaskovich, Mark A. T., Cooper, Matthew A., Skwarczynski, Mariusz and Toth, Istvan (2016). Short cationic lipopeptides as effective antibacterial agents: design, physicochemical properties and biological evaluation. Bioorganic and Medicinal Chemistry, 24 (10), 2235-2241. doi: 10.1016/j.bmc.2016.03.053
Edwards, Ingrid A., Elliott, Alysha G., Kavanagh, Angela M., Zuegg, Johannes, Blaskovich, Mark A. T. and Cooper, Matthew A. (2016). Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β‑hairpin peptides. ACS Infectious Diseases, 2 (6), 442-450. doi: 10.1021/acsinfecdis.6b00045
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
Gallardo-Godoy, Alejandra, Muldoon, Craig, Becker, Bernd, Elliott, Alysha G., Lash, Lawrence H, Huang, Johnny X., Butler, Mark S., Pelingon, Ruby, Kavanagh, Angela M., Ramu, Soumya, Phetsang, Wanida, Blaskovich, Mark A. T. and Cooper, Matthew A (2016). Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B. Journal of Medicinal Chemistry, 59 (3), 1068-1077. doi: 10.1021/acs.jmedchem.5b01593
Phetsang, Wanida, Pelingon, Ruby, Butler, Mark S., KC, Sanjaya, Pitt, Miranda, Kaeslin, Geraldine, Cooper, Matthew A. and Blaskovich, Mark A. T. (2016). Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli. ACS Infectious Diseases, 2 (10), 688-701. doi: 10.1021/acsinfecdis.6b00080
Clostridium difficile infection: current and emerging therapeutics
Jarrad, Angie M., Blaskovich, Mark A. T., Lyras, Dena and Cooper, Matthew A. (2015). Clostridium difficile infection: current and emerging therapeutics. Current Treatment Options in Infectious Diseases, 7 (4), 317-334. doi: 10.1007/s40506-015-0062-4
Mucin binding reduces colistin antimicrobial activity
Huang, Johnny X., Blaskovich, Mark A.T., Pelingon, Ruby, Ramu, Soumya, Kavanagh, Angela, Elliott, Alysha G., Butler, Mark S., Montgomery, A. Bruce and Cooper, Matthew A. (2015). Mucin binding reduces colistin antimicrobial activity. Antimicrobial Agents and Chemotherapy, 59 (10), 5925-5931. doi: 10.1128/AAC.00808-15
Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites
Jarrad, Angie M., Karoli, Tomislav, Anjan, Debnath, Tay, Chin Yen, Huang, Johnny X., Kaeslin, Geraldine, Elliott, Alysha G., Miyamoto, Yukiko, Ramu, Soumya, Kavanagh, Angela M., Zuegg, Johannes, Eckmann, Lars, Blaskovich, Mark A. and Cooper, Matthew A. (2015). Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites. European Journal of Medicinal Chemistry, 101 7946, 96-102. doi: 10.1016/j.ejmech.2015.06.019
Clostridium difficile drug pipeline: challenges in discover and development of new agents
Jarrad, Angie M., Karoli, Tomislav, Blaskovich, Mark A.T., Lyras, Dena and Cooper, Matthew A. (2015). Clostridium difficile drug pipeline: challenges in discover and development of new agents. Journal of Medicinal Chemistry, 58 (13), 5164-5185. doi: 10.1021/jm5016846
A new antibiotic with potent activity targets MscL
Iscla, Irene, Wray, Robin, Blount, Paul, Larkins-Ford, Johah, Conery, Annie L., Ausubel, Frederick M., Ramu, Soumya, Kavanagh, Angela, Huang, Johnny X., Blaskovich, Mark A., Cooper, Matthew A., Obregon-Henao, Andres, Orme, Ian, Tjandra, Edwin S., Stroeher, Uwe H., Brown, Melissa H., Macardle, Cindy, van Holst, Nick, Tong, Chee Ling, Slattery, Ashley D., Gibson, Christopher T., Raston, Colin L. and Boulos, Ramiz A. (2015). A new antibiotic with potent activity targets MscL. The Journal of Antibiotics, 68 (7), 453-462. doi: 10.1038/ja.2015.4
Helping chemists discover new antibiotics
Blaskovich, Mark A. T., Zuegg, Johannes, Elliott, Alysha G. and Cooper, Matthew (2015). Helping chemists discover new antibiotics. ACS Infectious Diseases, 1 (7), 285-287. doi: 10.1021/acsinfecdis.5b00044
Huang, Johnny Xiao, Geraldine Kaeslin, Max Ranall, Blaskovich, Mark, Bernd Becker, Butler, Mark, Little, Melissa H., Lash, Lawrence H. and Cooper, Matthew (2015). Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells. Pharmacology Research and Perspectives, 3 (3) e00148, e00148. doi: 10.1002/prp2.148
Azmi, Fazren, Elliott, Alysha G., Khalil, Zeinab G., Hussein, Waleed M., Kavanagh, Angela, Huang, Johnny X., Quezada, Michelle, Blaskovich, Mark A. T., Capon, Robert J., Cooper, Matthew A., Skwarczynski, Mariusz and Toth, Istvan (2015). Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains. Nanomedicine, 10 (22), 3359-3371. doi: 10.2217/nnm.15.137
Cell- and biomarker-based assays for predicting nephrotoxicity
Huang, Johnny X., Blaskovich, Mark A. and Cooper, Matthew A. (2014). Cell- and biomarker-based assays for predicting nephrotoxicity. Expert Opinion on Drug Metabolism and Toxicology, 10 (12), 1621-1635. doi: 10.1517/17425255.2014.967681
Glycopeptide antibiotics: back to the future
Butler, Mark S., Hansford, Karl A., Blaskovich, Mark A. T., Halai, Reena and Cooper, Matthew A. (2014). Glycopeptide antibiotics: back to the future. Journal of Antibiotics, 67 (9), 631-644. doi: 10.1038/ja.2014.111
Phetsang, Wanida, Blaskovich, Mark A. T., Butler, Mark S., Huang, Johnny Xiao, Zuegg, Johannes, Mamidyala, Sreeman K., Ramu, Soumya, Kavanagh, Angela M. and Cooper, Matthew A. (2014). An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants. Bioorganic and Medicinal Chemistry, 22 (16), 4490-4498. doi: 10.1016/j.bmc.2014.05.054
Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
Cheng, Mu, Ziora, Zyta M., Hansford, Karl A., Blaskovich, Mark A., Butler, Mark S. and Cooper, Matthew A. (2014). Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Organic and Biomolecular Chemistry, 12 (16), 2568-2575. doi: 10.1039/c3ob42428f
ChemInform abstract: lipoamino acids as major components of absorption promoters in drug delivery
Ziora, Zyta M., Blaskovich, Mark A., Toth, Istvan and Cooper, Matthew A. (2013). ChemInform abstract: lipoamino acids as major components of absorption promoters in drug delivery. ChemInform, 44 (43), no-no. doi: 10.1002/chin.201343267
Antibiotics in the clinical pipeline in 2013
Butler, Mark S., Blaskovich, Mark A. and Cooper, Matthew A. (2013). Antibiotics in the clinical pipeline in 2013. Journal of Antibiotics, 66 (10), 571-591. doi: 10.1038/ja.2013.86
Antibacterial serrulatane diterpenes from the Australian native plant Eremophila microtheca
Barnes, Emma C., Kavanagh, Angela M., Ramu, Soumya, Blaskovich, Mark A., Cooper, Matthew A. and Davis, Rohan A. (2013). Antibacterial serrulatane diterpenes from the Australian native plant Eremophila microtheca. Phytochemistry, 93, 162-169. doi: 10.1016/j.phytochem.2013.02.021
Resolving biofilm infections: current therapy and drug discovery strategies
Ranall, Max V., Butler, Mark S., Blaskovich, Mark A. and Cooper, Matthew A. (2012). Resolving biofilm infections: current therapy and drug discovery strategies. Current Drug Targets, 13 (11), 1375-1385. doi: 10.2174/138945012803530251
Lipoamino acids as major components of absorption promoters in drug delivery
Ziora, Zyta M., Blaskovich, Mark A., Toth, Istvan and Cooper, Matthew A. (2012). Lipoamino acids as major components of absorption promoters in drug delivery. Current Topics in Medicinal Chemistry, 12 (14), 1562-1580. doi: 10.2174/156802612802652448
Drug discovery and protein tyrosine phosphatases
Blaskovich, M. A. T. (2009). Drug discovery and protein tyrosine phosphatases. Current Medicinal Chemistry, 16 (17), 2095-2176. doi: 10.2174/092986709788612693
A convenient reduction of α-amino acids to 1,2-amino alcohols with retention of optical purity
Hwang, Sun-Hee, Blaskovich, Mark A. and Kim, Hwa-Ok (2008). A convenient reduction of α-amino acids to 1,2-amino alcohols with retention of optical purity. Open Organic Chemistry Journal, 2 (1), 107-109. doi: 10.2174/1874095200802010107
Design and synthesis of phosphotyrosine mimetics
Yan, Zheng, Kahn, Michael, Qabar, Maher, Urban, Jan, Kim, Hwa-Ok and Blaskovich, Mark (2003). Design and synthesis of phosphotyrosine mimetics. Bioorganic & Medicinal Chemistry Letters, 13 (12), 2083-2085. doi: 10.1016/S0960-894X(03)00253-1
Recent discovery and development of protein tyrosine phosphatase inhibitors
Blaskovich, Mark A. and Kim, Hwa-Ok (2002). Recent discovery and development of protein tyrosine phosphatase inhibitors. Expert Opinion on Therapeutic Patents, 12 (6), 871-905. doi: 10.1517/13543776.12.6.871
Rose, Nicholas G.W., Blaskovich, Mark A., Evindar, Ghotas, Wilkinson, Scott, Luo, Yue, Reid, C. and Lajoie, Gilles A. (2002). Preparation of 1-[N-Benzyloxycarbonyl-(1S)-1-amino-2-oxoethyl]-4-methyl-2,6,7-trioxabicyclo-[2.2.2]octane. Organic syntheses, 79, 216-221. doi: 10.1002/0471264180.os079.26
Rose, Nicholas G. W., Blaskovich, Mark A., Evindar, Ghotas, Wilkinson, Scott, Luo, Yue, Fishlock, Dan, Reid, Chris, Lajoie, Gilles A., Gordon, Richard S. and Holmes, Andrew B. (2002). Preparation of 1-[N-benzyloxycarbonyl-(1S)-1-amino-2-oxoethyl]-4-methyl-2,6,7-trioxabicyclo[2.2.2] octane: [Carbamic acid, [1-(4-methyl-2,6,7-trioxabicyclo[2.2.2]oct-1-yl)-2-oxoethyl]-, phenylmethyl ester, (S)-]. Organic Syntheses, 79 doi: 10.15227/orgsyn.079.0216
Synthesis of enantiomerically enriched beta,gamma-unsaturated-alpha-amino acids
Rose, Ngw, Blaskovich, MA, Wong, A and Lajoie, GA (2001). Synthesis of enantiomerically enriched beta,gamma-unsaturated-alpha-amino acids. Tetrahedron, 57 (8), 1497-1507. doi: 10.1016/S0040-4020(00)01146-7
Stereoselective synthesis of beta-substituted alpha,beta-diamino acids from beta-hydroxy amino acids
Luo, Y, Blaskovich, MA and Lajoie, GA (1999). Stereoselective synthesis of beta-substituted alpha,beta-diamino acids from beta-hydroxy amino acids. Journal of Organic Chemistry, 64 (16), 6106-6111. doi: 10.1021/jo9904718
Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics
Ogbu, CO, Qabar, MN, Boatman, PD, Urban, J, Meara, JP, Ferguson, MD, Tulinsky, J, Lum, C, Babu, S, Blaskovich, MA, Nakanishi, H, Ruan, FQ, Cao, BL, Minarik, R, Little, T, Nelson, S, Nguyen, M, Gall, A and Kahn, M (1998). Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics. Bioorganic & Medicinal Chemistry Letters, 8 (17), 2321-2326. doi: 10.1016/S0960-894X(98)00420-X
Polymer-supported acetylide addition to hexa-2,4-dienal
Blaskovich, MA and Kahn, M (1998). Polymer-supported acetylide addition to hexa-2,4-dienal. Synthesis-Stuttgart (7), 965-966.
Blaskovich, MA, Evindar, G, Rose, NGW, Wilkinson, S, Luo, Y and Lajoie, GA (1998). Stereoselective synthesis of Threo and Erythro beta-hydroxy and beta-disubstituted-beta-hydroxy alpha-amino acids (vol 63, pg 3635, 1998). Journal of Organic Chemistry, 63 (13), 4560-4560. doi: 10.1021/jo9849853
Regiocontrol in alkylations of alpha-silyl hydrazones
Blaskovich, MA and Rickards, RW (1998). Regiocontrol in alkylations of alpha-silyl hydrazones. Tetrahedron Letters, 39 (21), 3617-3620. doi: 10.1016/S0040-4039(98)00564-4
Blaskovich, MA, Evindar, G, Rose, NGW, Wilkinson, S, Luo, Y and Lajoie, GA (1998). Stereoselective synthesis of threo and erythro beta-hydroxy and beta-disubstituted-beta-hydroxy alpha-amino acids. Journal of Organic Chemistry, 63 (11), 3631-3646. doi: 10.1021/jo972294l
Mild conditions for oxazolidin-5-one formation
Blaskovich, MA and Kahn, M (1998). Mild conditions for oxazolidin-5-one formation. Synthesis-Stuttgart (4), 379-380.
Solid-phase preparation of dienes
Blaskovich, MA and Kahn, M (1998). Solid-phase preparation of dienes. Journal of Organic Chemistry, 63 (4), 1119-1125. doi: 10.1021/jo9715884
Stereoselective Synthesis of Allo-Threonine and Beta-H-2-Allo-Threonine From Threonine
Blaskovich, MA and Lajoie, GA (1993). Stereoselective Synthesis of Allo-Threonine and Beta-H-2-Allo-Threonine From Threonine. Tetrahedron Letters, 34 (24), 3837-3840. doi: 10.1016/S0040-4039(00)79241-0
Blaskovich, MA and Lajoie, GA (1993). Synthesis of a Chiral Serine Aldehyde Equivalent and its Conversion to Chiral Alpha-Amino-Acid Derivatives. Journal of the American Chemical Society, 115 (12), 5021-5030. doi: 10.1021/ja00065a010
Adamson, JG, Blaskovich, MA, Groenevelt, H and Lajoie, GA (1991). Simple and Convenient Synthesis of Tert-Butyl Ethers of Fmoc-Serine, Fmoc-Threonine, and Fmoc-Tyrosine. Journal of Organic Chemistry, 56 (10), 3447-3449. doi: 10.1021/jo00010a050
Hall, Lisa, Lawler, Sheleigh, Comans, Tracy, Reid, Simon, Soares Magalhães, Ricardo, Blaskovich, Mark, Henseleit, Julia and Welch, Alyssa (2023). Developing the monitoring and evaluation framework for ‘Australia’s antimicrobial resistance strategy: 2020 and beyond’ using a one health approach. 17th World Congress on Public Health, Rome, Italy, 2-6 May 2023. Heraklion, Greece: EU European Publishing. doi: 10.18332/popmed/163919
WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds
Mirzaee, Hooman, Ariens, Emily, Booth, James, Carvalhais, Lilia C., Blaskovich, Mark A.T., Clark, Richard J. and Schenk, Peer M. (2022). WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27 – 30 November 2022. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/s2213-7165(22)00272-7
Antibiotic-derived molecular probes for bacterial imaging
Blaskovich, Mark A., Phetsang, Wanida, Stone, M. Rhia L., Lapinska, Urszula, Pagliara, Stefano, Bhalla, Rajiv and Cooper, Matthew A. (2019). Antibiotic-derived molecular probes for bacterial imaging. SPIE BiOS 2019, San Francisco, California, 2-7 February 2019. Bellingham, WA United States: SPIE - International Society for Optical Engineering. doi: 10.1117/12.2507329
Edwards, I., Elliott, A., Blaskovich, M. and Cooper, M. (2016). Contribution of physicochemical parameters to the antimicrobial activity / toxicity index of B-Hairpin peptides. 34th European Peptide Symposium, Leipzig, Germany, 4‐9 September 2016. Oxford, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2950
New glycopeptidic antibiotics to combat multidrug resistant pathogens
Gong, Y., Muldoon, C. A., Premraj, R., Ziora, Z. M., Bradford, T. A., Cheng, M., Ramu, S., Huang, J. X., Kavanagh, A., Pelingon, R., Lee, J. C., Wong, K., Butler, M. S., Blaskovich, M. A. and Cooper, M. A. (2012). New glycopeptidic antibiotics to combat multidrug resistant pathogens. 32nd European Peptide Symposium, Athens, Greece, 2-7 September 2012. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2449
Paparin, JL, Hwang, SH, Nguyen, M, Zheng, Y, Ruan, FQ, Little, T and Blaskovich, MA (2001). 4-substituted urazoles from amino acids: Useful building-blocks for the synthesis of beta-strand peptidomimetics.. WASHINGTON: AMER CHEMICAL SOC.
Design and synthesis of phosphotyrosine mimetic phenylalanine derivatives.
Kim, HO, Yan, Z, Blaskovich, M and Kahn, M (2001). Design and synthesis of phosphotyrosine mimetic phenylalanine derivatives.. WASHINGTON: AMER CHEMICAL SOC.
Facile synthesis of alpha-amino alcohols from alpha-amino acids.
Hwang, SH, Blaskovich, M and Kim, HO (2001). Facile synthesis of alpha-amino alcohols from alpha-amino acids.. WASHINGTON: AMER CHEMICAL SOC.
Blaskovich, MA, Boatman, PD, Cao, BL, Eguchi, M, Kim, HO, Lee, M, Little, T, Mathew, F, McCann, I, Mehlin, C, Nakanishi, H, Nelson, S, Nguyen, M, Ogbu, C, Qabar, MN, Ruan, FQ, Shea, JP, Stasiak, M, Urban, J and Kahn, M (2000). Highly efficient and versatile construction of secondary structure peptide mimetic libraries: Application to biology and drug development. 16th American Peptide Symposium, Minneapolis Mn, Jun 26-Jul 01, 1999. DORDRECHT: SPRINGER.
Rapid Radiolabelling of Quinuclidinyl P-Iodobenzilate with I-123
Abeysekera, BF, Swinkels, HM, Blaskovich, MA, Reba, RC and Gibson, RE (1988). Rapid Radiolabelling of Quinuclidinyl P-Iodobenzilate with I-123. OTTAWA: CANADIAN MEDICAL ASSOCIATION.
Matthew Cooper, Mark Blaskovich, Alejandra Gallardo-Godoy, Karl Hansford, Alysha Elliott, Carig Muldoon and Bernd Becker (2022). Peptide Antibiotics. US11279733.
Cooper, Matthew and Blaskovich, Mark (2021). Antibacterial Agents. CN107027309.
Cooper, Matthew and Blaskovich, Mark (2021). Antibacterial Agents. US10947271.
Cooper, Matthew and Blaskovich, Mark (2020). Antibacterial Agents. EP3105244.
Cooper, Matthew and Blaskovich, Mark (2019). Antibacterial Agents. JP6602318.
Cooper, Matthew and Blaskovich, Mark (2019). Antibacterial Agents. AU2015/213478.
Gallardo-Goday, Alejandra, Cooper, Matthew, Blaskovich, Mark, Hansford, Karl and Elliott, Alysha (2019). Peptide antibiotics. WO2019084628.
Glycopeptide Antibiotic Constructs
Mark Blaskovich, Matt Cooper, Andrea Ranzoni, Wanida Phetsang and Marwa Hassan (2018). Glycopeptide Antibiotic Constructs. WO/2018/102889.
Mark Blaskovich, Matt Cooper, Mark Butler, Rhia Stone and Wanida Phetsang (2018). Visualisation Constructs. WO/2018/102890.
Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2016). Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor. US9340517.
Cooper, Matthew and Blaskovich, Mark (2015). Antibacterial Agents. WO/2015/117196.
3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists
Mark Arnold Thomas Blaskovich and Pater Joseph Cassidy (2013). 3-Substituted-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8440653 .
Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor. US8377925.
“3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists
Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8343958.
3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists
Mark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2011). 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8008291.
Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof
Mark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, Maher Qabar, Lauri Marie Schultz, Feng Hong, William Pratt, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2010). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7829737.
Blaskovich, Mark and CASSIDY P J (2010). Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound. WO2010096853-A1.
Blaskovich, Mark and CASSIDY P J (2010). Modulating the activity of a receptor comprising melanocortin-3 receptor or melanocortin-4 receptor, comprises exposing the receptor to 1,4-diazepan-2-one compounds. WO2010096854-A1.
BLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105825-A1.
BLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105823-A1.
BLASKOVICH M A T and CASSIDY P J, (2009). Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitis. WO2009105824-A1.
Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof
Mark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, William Pratt, Maher Qabar, Laurie Marie Schultz, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2009). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7504389.
Protein tyrosine phosphatase inhibitors and methods of use thereof
Blaskovich, Mark Arnold Thomas, Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2009). Protein tyrosine phosphatase inhibitors and methods of use thereof. US 07504389.
Protein tyrosine phosphatase inhibitors and methods of use thereof
Blaskovich, Mark A., Little, Thomas, Qabar, Maher, Schultz, Lauri, Gage, Jennifer Lynn, Hong, Feng, Baughman, Ted, Patt, William, Howbert, James Jeffry and Nagula, Gangadhar (2006). Protein tyrosine phosphatase inhibitors and methods of use thereof. US2006142250(A1).
beta-sheet mimetics and composition and methods relating thereto
Blaskovich, Mark A., Ogbu, Cyprian, O. and Kim, Hwa-Ok (2006). beta-sheet mimetics and composition and methods relating thereto. US7053214(B2).
Protein tyrosine pPhosphatase inhibitors and methods of use thereof
Blaskovich, Mark A., Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Hong, Feng, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2006). Protein tyrosine pPhosphatase inhibitors and methods of use thereof. WO/2006/055525.
Beta-sheet mimetics and composition and methods relating thereto
Ogbu, Cyprian O., Kim, Hwa-Ok and Blaskovich, Mark, A. (2003). Beta-sheet mimetics and composition and methods relating thereto. WO/2003/068237.
(2023–2028) ARC Industrial Transformation Training Centres
(2023–2024) Griffith University
(2023) CSIRO
(2022–2024) University of Exeter
(2022) CSIRO
(2021–2024) NHMRC IDEAS Grants
Advanced Nuclear Magnetic Resonance Technologies for Southeast Queensland
(2021–2023) ARC Linkage Infrastructure, Equipment and Facilities
Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance
(2021–2023) NHMRC IDEAS Grants
OctapeptinX Potentiators to treat XDR Gram-negative infections
(2021–2023) NHMRC Development Grant
A study of the antimicrobial efficacy of Calix bioactive materials
(2021–2022) Calix Limited
(2020–2025) University of Melbourne
Breaking antibiotic resistance in high priority Gram-negative sepsis pathogens
(2020–2023) NHMRC Development Grant
Cannabodiol analog synthesis and characterisation
(2020) Botanix Pharmaceuticals Ltd
Sequencing Analysis of CBD-Induced Resistance S. saprophyticus
(2020) Botanix Pharmaceuticals Ltd
Antibacterial Potentiation Screening 1. Master Research Services Agreement - Statement of Work no.3
(2019–2020) Global Antibiotic Research & Development Partnership Foundation
Continued Investigations into the Antimicrobial Activity of Cannabidiol
(2019–2020) Innovation Connections
Antibacterial Potentiation Screening 1. Master Research Services Agreement - Statement of Work no.2
(2019) Global Antibiotic Research & Development Partnership Foundation
Antibacterial Screening 1. Master Research Services Agreement - Statement of Work no.1
(2019) Global Antibiotic Research & Development Partnership Foundation
In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
(2019) UQ Major Equipment and Infrastructure
Lipopeptide antibiotics for XDR Gram-negative infections
(2018–2021) NHMRC Development Grant
Rapid Diagnosis of Microbial Infections Without Culture
(2018–2021) Defence Materials Technology Centre
Investigations into the Antimicrobial Activity of Cannabidiol
(2018–2019) Innovation Connections
(2017–2023) The Wellcome Trust
Rapid diagnosis of pathogenic infections
(2017–2020) Queensland Government Advance Queensland Innovation Partnerships
Antibody-antibiotic conjugates to treat drug-resistant Gram-ve infections
(2017–2018) Global Connections Fund
Natureceuticals from post-production wine extracts
(2017–2018) Innovation Connections
Natureceuticals from post-production wine extracts
(2017) Innovation Connections
Novel membrane-targeted antibiotics against drug-resistant Gram-positive bacterial infections
(2016–2019) NHMRC Development Grant
Community for Open Antimicrobial Drug Discovery (CO-ADD) Indonesian Engagement Program
(2016–2017) Commonwealth Department of Foreign Affairs & Trade
Antibody-antibiotic conjugates to treat drug-resistant bacteria
(2016) Global Connections Fund
Community for Open Antimicrobial Drug Discovery (CO-ADD)
(2015–2019) The Wellcome Trust
Antimicrobial activity of MTC896 against common skin bacteria
(2014–2015) UniQuest Pty Ltd
Effect of Sputum Surrogate on Amikacin activity with and without fosfomycin
(2014–2015) UniQuest Pty Ltd
Continuous-Flow Hydrogenation Reactor (H-Cube Pro)
(2014) UQ Major Equipment and Infrastructure
Enrichment, detection and identification of bacteria in blood and urine.
(2014) UQ Collaboration and Industry Engagement Fund - Seed Research Grant
Understanding Molecular Accumulation in antimicrobial resistant microbes
Doctor Philosophy — Principal Advisor
Investigations of novel antimicrobial agents and formulations to treat topical agricultural infections.
Doctor Philosophy — Principal Advisor
Other advisors:
Clicking Conjugates into Place for the Fight Against Antibiotic Resistance
Doctor Philosophy — Principal Advisor
Other advisors:
Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance
Doctor Philosophy — Principal Advisor
Other advisors:
Novel antibiotics containing tyrosinase inhibitors
Doctor Philosophy — Principal Advisor
Other advisors:
Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance
Doctor Philosophy — Principal Advisor
Other advisors:
Disrupting Bacterial Proteostasis through ClpP Activation
Doctor Philosophy — Principal Advisor
Other advisors:
Synthesis and bio-evaluation of tyrosinase inhibitors as potential anti-melanoma agents and novel treatment for Parkinson's disease
Doctor Philosophy — Principal Advisor
Other advisors:
Nanocellulose-based hydrogel for flexible electronic applications
Doctor Philosophy — Associate Advisor
Other advisors:
Synthesis and Physico-chemical characterization of waste derived carbon adsorbents for wastewater treatment
Doctor Philosophy — Associate Advisor
Other advisors:
Targeting the Biogenesis of Resistance Enzymes to Combat Antimicrobial Resistance
Doctor Philosophy — Associate Advisor
Other advisors:
Conotoxins - advanced probes for studying pain pathways
Doctor Philosophy — Associate Advisor
Other advisors:
Development of Metal Organic Frameworks for targeted oral drug delivery
Doctor Philosophy — Associate Advisor
Other advisors:
How does cannabidiol kill bacteria?
Doctor Philosophy — Associate Advisor
Other advisors:
Antibiotic potentiators as an alternative therapeutic option for the treatment of extensively drug-resistant Gram-negative infections.
Doctor Philosophy — Associate Advisor
Other advisors:
Development of Biobased Silver Nano-Particles for Application as Wastewater Disinfectant
Doctor Philosophy — Associate Advisor
Other advisors:
Development of computational models to discover new antibiotics against Gram-negative bacteria. (Note: online component of Onawole's application lists his Master's thesis title instead of this project)
Doctor Philosophy — Associate Advisor
Other advisors:
Targeting bacterial biofilms in patients with gastrointestinal disorders
Doctor Philosophy — Associate Advisor
Other advisors:
A global quantitative genetic network for Escherichia coli
Doctor Philosophy — Associate Advisor
Other advisors:
Investigations of the interactions between fluorescent antibiotics and bacteria
Doctor Philosophy — Associate Advisor
Other advisors:
Slipping out unnoticed: a new bacterial lipoprotein transport system
Doctor Philosophy — Associate Advisor
Other advisors:
(2023) Doctor Philosophy — Principal Advisor
Other advisors:
(2023) Doctor Philosophy — Principal Advisor
Development of new bicyclic nitroimidazoles as antimicrobial agents
(2020) Doctor Philosophy — Principal Advisor
Genotypic and phenotypic characterisation of Gram-positive antibiotics
(2020) Doctor Philosophy — Principal Advisor
Tagged Antibiotics for Examination of Bacterial Resistance and Infection
(2020) Doctor Philosophy — Principal Advisor
Other advisors:
ß-hairpin antimicrobial peptides: structure, function and mode of action
(2018) Doctor Philosophy — Principal Advisor
Other advisors:
Azide-antibiotics and fluorescent probes
(2017) Doctor Philosophy — Principal Advisor
Advanced Formulation Technologies for Oral Delivery of Antimicrobial Agents
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
Investigating the Immunopharmacology of the Complement C5a Receptors, C5aR1 and C5aR2
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
(2018) Doctor Philosophy — Associate Advisor
Novel Nitroimidazole and Glycopeptide Antibiotics Targeting Enteric Pathogens
(2016) Doctor Philosophy — Associate Advisor
Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.
Functionalised antibiotics for diagnostics and therapeutics
The increasing incidence of infections caused by drug resistant bacteria and fungi poses a significant and increasing threat to global human health, with predicted annual mortality of 10 million people by 2050. It is imperative to advance new technologies capable of rapidly and accurately diagnosing infections to enable timely and appropriate therapy. We must develop new antibiotics with efficacy against multidrug-resistant bacteria and fungi, and new methods to rapidy diagnose infections. To enable this we require fundamental studies that probe the chemical biology of antibiotic action and investigate microbial growth, metabolism and resistance.
This research program is designed to achieve these goals, based on the chemical functionalisation of antibiotics with a readily derivatised handle. The resulting set of versatile intermediates is then modified to create 1) fluorescent probes that can catalyse basic research and lead to new assays, 2) clinical imaging agents to visualise microbial infections, and 3) novel hybrid therapeutics. The project requires talented synthetic organic chemists with an interest in multidisciplinary research.